Title	Publication Date	Language	Citations
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies	2018/03/07	English
Acknowledgement to Referees	2015/11/19	English
Quantitative Methods for Prediction of the Effect of Cytochrome P450 Gene Polymorphisms on Substrate Drug Exposure: Authors’ Reply	2014/12/09	English
Quantitative Methods for Prediction of the Effect of Cytochrome P450 Gene Polymorphisms on Substrate Drug Exposure	2015/01/06	English
Author’s Reply to Proost: “Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients”	2016/12/29	English
Author’s Reply to De Ponti et al.: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”	2015/02/27	English
Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”	2020/03/31	English
Author’s Reply to Reith: “Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults”	2018/06/23	English
Acknowledgement to Referees	2018/11/15	English
Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”	2020/10/28	English
Population Pharmacokinetic Analysis to Assist Dose Selection of the l-Ornithine Salt of Phenylacetic Acid	2021/11/17	English
Authors’ Reply to Suhas et al.: Comment on: “Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation”	2021/04/26	English
A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021	2022/10/31	English
Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling	2022/09/30	English
Authors’ Reply: Pharmacokinetic and Pharmacodynamic Drug Interactions Between Antiretrovirals and Oral Contraceptives	2015/03/03	English
Propofol Clearance in Morbidly Obese Children and Adolescents	2012/08/01	English
Prediction of Clearance and Volume of Distribution in the Obese from Normal Weight Subjects	2012/08/01	English
Diabetes Mellitus Reduces the Clearance of Atorvastatin Lactone	2012/09/01	English
Evaluation of 5-Fluorouracil Pharmacokinetics in Cancer Patients with a C.1905+1G>A Mutation in DPYD by Means of a Bayesian Limited Sampling Strategy	2012/03/01	English
Obesity and Its Impact on Drug Therapy	2011/12/01	English
Erratum	2011/12/01	English
Acknowledgement	2011/12/01	English
The Authorsʼ Reply	2009/05/01	English
The Authorsʼ Reply	2009/10/01	English
Population Pharmacokinetic/Pharmacodynamic Modelling of Dipeptidyl Peptidase IV Inhibitors	2015/05/05	English
Acknowledgement to Referees	2013/11/09	English
Erratum	2011/10/01	English
Erratum	2011/09/01	English
Clinical Pharmacokinetics Preferred Symbols	1996/07/01	English
Current Literature References on Clinical Pharmacokinetics	1980/01/01	English